Lucideon to Exhibit at Making Pharmaceuticals 2015
Lucideon is pleased to announce that it will be exhibiting at Making Pharmaceuticals 2015 showcasing its new, state-of-the-art, pharmaceutical quality control (QC) testing services.
Lucideon has over 60 years’ experience in materials testing and analysis and has recently invested £1.5Million in new pharmaceutical QC testing facilities. With a dedicated team of experienced staff Lucideon offers an extensive range of chemical and microbiological services, which includes QC (batch release) testing, raw materials and residual solvent testing, method development and validation, bioburden determination, sterility testing and much more.
Parmjit Bilan, Pharmaceutical Business Development Manager for Lucideon said:
“This will be a fantastic opportunity to meet with industry professionals and to show them what we offer and why we’re different to other testing organizations.
“We are unique in that we offer extensive back up analytical services, such as advanced surface analysis, and can draw on years of experience in materials development across many different industries.”
Lucideon’s work in materials development includes inorganic controlled release technologies (iCRT) drug delivery platforms where release can be tailored over different time periods, from minutes to days. iCRT-deter is a novel drug delivery platform developed with iCRT technology that has valuable applications in drug abuse deterrence.
Lucideon can be found on Stand 209 at Making Pharmaceuticals at the NMM Exhibition Centre, Birmingham on the 28th and 29th of April. To find out more please visit www.making-pharma.com